InsiderSignal.AI

InsiderSignal.ai

ALMR - Alamar Biosciences, Inc.

Insider Purchase by Naclerio Nicholas (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

Yesterday, Naclerio Nicholas, serving as Dir at Alamar Biosciences, Inc. (ALMR), purchased 235,294 shares at $17.00 per share, for a total transaction value of $3,999,998.00. Following this transaction, Naclerio Nicholas now holds 512,762 shares of ALMR.

This purchase represents a 85.00% increase in Naclerio Nicholas's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 20, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 20, 2026, meaning the disclosure happened on the same day as the trade.

Alamar Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Naclerio Nicholas

Naclerio Nicholas

Dir

Nicholas Naclerio, Ph.D. (born circa 1962) is an accomplished biotechnology executive and venture capitalist serving as an Independent Director on the board of Alamar Biosciences, Inc. (ALMR) since April 30, 2020.[[1]](https://www.marketscreener.com/quote/stock/ALAMAR-BIOSCIENCES-INC-208175911/company-governance/)[[2]](https://www.moomoo.com/stock/ALMR-US/company)[[6]](https://www.sec.gov/Archives/edgar/data/2104204/000119312526159789/d620616ds1mef.htm) He recently filed as a director and insider on April 16, 2026, ahead of the company's NASDAQ listing.[[4]](https://www.otcmarkets.com/filing/html?id=19347849&guid=NkS-kp1NXQcpJth)[[7]](https://www.streetinsider.com/SEC+Filings/Form+3+Alamar+Biosciences,+Inc.+For:+Apr+16+Filed+by:+Naclerio+Nicholas/26326569.html) Naclerio is the Founding Partner of Illumina Ventures, where he focuses on building companies at the technology-health intersection, with Alamar Biosciences in his portfolio.[[3]](https://www.illuminaventures.com/team/nick-naclerio-ph-d/) His career highlights include SVP of Corporate & Venture Development at Illumina Inc., leading acquisitions, investments, and formations like Helix and GRAIL; founding General Manager of Illumina’s Enterprise Informatics; co-founding and chairing Quanterix; CEO of ParAllele BioScience (acquired by Affymetrix); and leading Motorola Life Sciences (acquired by GE).[[3]](https://www.illuminaventures.com/team/nick-naclerio-ph-d/) He holds a B.S. in Engineering from Duke University, was a Winston Churchill Scholar at Cambridge, and earned a Ph.D. in Electrical Engineering from the University of Maryland.[[3]](https://www.illuminaventures.com/team/nick-naclerio-ph-d/)

View full insider profile →

Trade Price

$17.00

Quantity

235,294

Total Value

$3,999,998.00

Shares Owned

512,762

Trade Date

Monday, April 20, 2026

1 days ago

SEC Filing Date

Monday, April 20, 2026

HEALTHCAREMEDICAL DEVICES

About Alamar Biosciences, Inc.

Company Overview

No company information available
View news mentioning ALMR

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5811144

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime